Systematic review and economic analysis of the comparative effectiveness of different inhaled corticosteroids and their usage with long-acting beta2 agonists for the treatment of chronic asthma in children under the age of 12 years
Health Technology Assessment
NIHR Health Technology Assessment Programme
To assess the clinical and cost-effectiveness of inhaled corticosteroids (ICS) alone and ICS used in combination with a long-acting beta2 agonist (LABA) in the treatment of chronic asthma in children aged under 12 years.
addresses: Peninsula Technology Assessment Group (PenTAG), Peninsula Medical School, Universities of Exeter and Plymouth, Exeter, UK.
types: Journal Article; Meta-Analysis; Review
Published version. Copyright © 2008 NIHR Health Technology Assessment Programme
Health Technology Assessment, 2008, Vol. 12, Issue 20, pp. 1 - iv
Place of publication